WallStSmart
NRIX

Nurix Therapeutics Inc

NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY

$16.70
+0.54% today

Updated 2026-04-30

Market cap
$1.72B
P/E ratio
P/S ratio
23.93x
EPS (TTM)
$-3.17
Dividend yield
52W range
$8 – $23
Volume
1.1M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$30.24
+81.08%
12-Month target
Intrinsic (DCF)
$24.33
Margin of safety
+33.79%
5 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 33.79% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-72.96M
- Revenue declining -66.10% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$38.63M$76.99M$54.55M$83.98M$71.78M
Net income$-166.04M$-143.95M$-193.57M$-264.46M$-87.17M
EPS$-3.17
Free cash flow$-172.05M$-89.77M$-181.86M$-263.47M$-72.96M
Profit margin-429.87%-186.98%-354.85%-314.90%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
NRIX$1.72B235.32.56.75.0+33.79%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Nurix Therapeutics Inc trades at $16.70. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $71.78M. Our DCF model estimates intrinsic value at $24.33.

Frequently asked questions

What is Nurix Therapeutics Inc's stock price?
Nurix Therapeutics Inc (NRIX) trades at $16.70.
Is Nurix Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $24.33.
What is the price target of Nurix Therapeutics Inc (NRIX)?
The analyst target price is $30.24, representing +81.1% upside from the current price of $16.70.
What is the intrinsic value of Nurix Therapeutics Inc (NRIX)?
Based on our DCF model, intrinsic value is $24.33, a +33.8% margin of safety versus $16.70.
What is Nurix Therapeutics Inc's revenue?
TTM revenue is $71.78M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio23.93x
ROE-61.40%
Beta1.98
50D MA$15.81
200D MA$14.05
Shares out0.10B
Float0.10B
Short ratio
Avg volume1.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years